Skip to main content

Volume 14 Supplement 2

Sepsis 2010

Kinetics of TREM-1 expression on canine neutrophils after in vitro and in vivo stimulation with microbial products

The triggering receptor expressed on myeloid cells-1 (TREM-1) is a recently discovered cell surface molecule expressed on neutrophils, mature monocytes, and macrophages [1]. Activation of TREM-1 synergistically enhances proinflammatory cytokine production induced by toll-like receptor (TLR) stimulation [2]. A soluble form of TREM-1 has shown promise as a sensitive and specific biomarker for sepsis in humans [35]. Expression and function of TREM-1 in the dog has yet to be characterized. We hypothesize that the expression of canine TREM-1 will be upregulated after stimulation with TLR agonists. We assessed TREM-1 expression on canine neutrophils after exposure to TLR agonists in vitro and in vivo after i.v. LPS administration. In vitro, expression of TREM-1 on neutrophils is significantly upregulated by stimulation with microbe-derived agonists against TLR2/6 (Pam2CSK4), TLR1/2 (Pam3CSK4), and TLR4/MD2 (ultrapure LPS and wildtype LPS) (paired t test, P < 0.05). The TLR5 agonist flagellin did not significantly upregulate TREM-1 expression at any time point. See Figure 1. In contrast, i.v. administration of LPS to dogs resulted in a significant decrease in both TREM-1 expression and the percentage of TREM-1-positive neutrophils from 6 hours through 12 hours post LPS administration. See Figure 2. The disparity between in vitro and in vivo effects of LPS suggest other factors, such as systemic and local cytokine production and neutrophil turnover, may influence expression and shedding of TREM-1 on canine neutrophils. We suggest that naturally occurring sepsis in the dog represents the ideal model for defining diagnostic biomarkers and discovering efficacious therapeutics for use in human sepsis.

Figure 1
figure1

Kinetics of TREM-1 expression after TLR agonist stimulation in vitro.

Figure 2
figure2

Kinetics of TREM-1 expression post LPS administration in vivo.

References

  1. 1.

    Bouchon A, Dietrich J, Colonna M: Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 2000, 164: 4991-4995.

    CAS  Article  PubMed  Google Scholar 

  2. 2.

    Bouchon A, Facchetti F, Weigand MA, Colonna M: TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001, 410: 1103-1107. 10.1038/35074114

    CAS  Article  PubMed  Google Scholar 

  3. 3.

    Gibot S, Kolopp-Sarda MN, Bene MC, et al.: Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med 2004, 141: 9-15.

    CAS  Article  PubMed  Google Scholar 

  4. 4.

    Gibot S, Cravoisy A, Levy B, et al.: Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 2004, 350: 451-458. 10.1056/NEJMoa031544

    CAS  Article  PubMed  Google Scholar 

  5. 5.

    Gibot S, Cravoisy A: Soluble form of the triggering receptor expressed on myeloid cells-1 as a marker of microbial infection. Clin Med Res 2004, 2: 181-187. 10.3121/cmr.2.3.181

    PubMed Central  CAS  Article  PubMed  Google Scholar 

Download references

Acknowledgements

This presentation was supported by Morris Animal Foundation and ICARE.

Author information

Affiliations

Authors

Corresponding author

Correspondence to J Li.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Li, J., Birkenheuer, A., Levy, M. et al. Kinetics of TREM-1 expression on canine neutrophils after in vitro and in vivo stimulation with microbial products. Crit Care 14, P35 (2010). https://doi.org/10.1186/cc9138

Download citation

Keywords

  • Cytokine Production
  • Surface Molecule
  • Microbial Product
  • Cell Surface Molecule
  • Proinflammatory Cytokine Production
\